Covaxin gets emergency use approval from DCGI for children above 12 years

Covaxin gets emergency use approval from DCGI for children above 12 years Bharat Biotech informed that Covaxin is documented with excellent safety and immunogenicity data readouts in children https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Women in India Report Higher Sleep Deprivation Than Men

Nadda reviews healthcare delivery mechanisms in Rajasthan, Maharashtra

ICMR to roll out multi-state study to expand palliative care access